Oral Session 2-13A MDS：Basic (1)

[OS2-13A-2] The role of compound DDX41 germline and somatic mutations in myeloid neoplasms

Ayana Kon¹, Masahiro Nakagawa¹, Yasuhito Nanya¹, Keisuke Kataoka^1,2, Yotaro Ochi¹, June Takeda¹, Kenichi Yoshida¹, Manabu Nakayama³, Haruhiko Koseki⁴, Hideki Makishima¹, Seishi Ogawa¹ (1.Dept. Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 2.Div. Molecular Oncology, National Cancer Center Japan Research Inst., Tokyo, Japan, 3.Dept. Technology Development, Kazusa DNA Research Inst., Chiba, Japan, 4.Lab. Developmental Genetics, RIKEN Center Integrative Medical Sciences, Yokohama, Japan)